Solutions / Insurance

The high-risk cardiovascular member is where the book loses money. That is the population the Institute studies.

Continuous cardiovascular intelligence is field science for the members who already dominate medical loss, not a broad wellness layer.

Heart failure and related cardiovascular disease drive repeated admissions and emergency use. Nationally, 19.7% of heart-failure discharges still return within 30 days (CMS Care Compare, July 2021 through June 2024). CHAMP-HF found that fewer than 1% of eligible HFrEF patients were simultaneously on target doses of ACEI/ARB/ARNI, a beta-blocker, and an MRA. The gap is titration and late recognition, not another claims edit.

A modeled target used in Institute planning is a 25% per-member-per-month cost reduction for the high-risk cardiovascular population managed under a continuous operating-system posture. That figure is a model target, not a measured multi-payer result and not a CMS statistic. It is meant to be walked against a plan's own PMPM and admission profile.

Published field outcomes remain the Prevail Heart Clinics cohort (October 2014 through May 2016, n=394, care predominantly by a physician assistant): 71.4% reduction in heart-failure hospitalizations in the first year, and 6.1% all-cause 30-day readmission against a 24.7% contemporaneous Medicare CHF benchmark. Presented at the 27th European Cardiology Conference (Rome, October 2018) and published in the Journal of Clinical & Experimental Cardiology, Volume 9, authored by Dr. Kevin A. Courville. They are not 2026 multi-payer results. A larger outcomes refresh is underway.

2026 performance research on the recording (12-lead strip equivalence, n=61; long-term arrhythmia detection versus Holter, n=52, every reported endpoint above 75% sensitivity and 75% PPV) is the measurement foundation under that 25% model: a continuous signal accurate enough to manage the high-risk book.

Monitoring and management in the U.S. sit on existing CMS remote physiologic monitoring and cardiac monitoring codes. Decision support in this science is assistance for the treating clinician, not autonomous diagnosis or treatment.